PRAM1 and neoplasm: The results showed that the high expression of TNFAIP6 and TLR6, as well as the low expression of P2RY13, SCARF1, DPEP2, PRAM1, CYP27A1, CFP, GPX3, and NCF1 might be closely associated with pro-tumor effects (Figure 6).